(Press-News.org) About The Study: Between 2021 and 2023, prevalence of current cannabis use increased among adults age 65 or older nationally, with key demographic subgroups experiencing marked increases. Adults with the highest incomes initially had the lowest prevalence of cannabis use vs other income levels, but by 2023, they had the highest prevalence, which may indicate better access to medical cannabis given its costs.
Corresponding Author: To contact the corresponding author, Benjamin H. Han, MD, email b2han@health.ucsd.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamainternmed.2025.1156)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2025.1156?guestAccessKey=bbd1a6af-2e2a-4b02-b44d-ea201d97515c&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=060225
END
Trends in past-month cannabis use among older adults
JAMA Internal Medicine
2025-06-02
ELSE PRESS RELEASES FROM THIS DATE:
How to create aqueous 100 nm-sized materials with polycavities
2025-06-02
While molecues with a single cavity have been extensively studied in solution, the solution state functions of polycavity materials remain elusive owing to their synthetic inaccessibility. Porous aromatic polymers (PAPs) are synthesized in a single step and offer polymeric cavity frameworks with high stability, which are applicable to gas and molecule adsorption/separation only in the solid state. Due to their strong aggregation-derived insoubility, unsubstituted PAPs cannot be used in any solvent until now.
To move the functions of PAPs from the solid to the solution ...
Epilepsy is more common in patients with frontotemporal dementia than expected
2025-06-02
According to a recent study, in patients with frontotemporal dementia (FTD), epileptic seizures are significantly more common than previously known. The discovery deepens understanding of the symptoms of this memory disorder and emphasises the importance of taking epileptic seizures into account in the treatment and monitoring of patients.
Coordinated by Neurocenter Finland, this major project by the University of Eastern Finland and the University of Oulu examined the prevalence of epilepsy in patients with FTD. The research dataset ...
Pre-operative THP leads to a pCR in two-thirds of early-stage HER2+ ER- breast cancer patients
2025-06-02
Patients with Stage II and III (early-stage) HER2+ breast cancer usually undergo pre-operative therapy with multi-agent chemotherapy in combination with anti-HER2 antibodies, followed by surgery. A less intensive, reduced chemotherapy treatment approach is currently being evaluated in the CompassHER2 pCR trial (EA1181, NCT04266249) by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN). While longer follow-up is needed to assess long-term outcomes, pathologic complete response (pCR) rates and predictors of ...
Immune system discovery reveals potential solution to Alzheimer’s
2025-06-02
A new way of thinking about Alzheimer’s disease has yielded a discovery that could be the key to stopping the cognitive decline seen in Alzheimer’s and other neurodegenerative diseases.
University of Virginia School of Medicine scientists have been investigating the possibility that Alzheimer’s is caused, at least in part, by the immune system’s wayward attempts to fix DNA damage in the brain. Their research reveals that an immune molecule called STING drives the formation of the harmful plaques and protein ...
Salamanders suffering from rising temperatures
2025-06-02
FRANKFURT. Habitat loss, diseases, pollution, and climate change are already massively affecting amphibians – frogs, salamanders, and the caecilians native to tropical regions. The new study from the Institute for Ecology, Evolution and Diversity shows that extreme weather events serve as an additional stress factor, further intensifying this crisis. For this purpose, the scientists analyzed global weather data from the past 40 years. They compared regions with significantly increased heat waves, droughts, and cold spells with the geographical ...
It’s not too late to start eating better for your brain
2025-06-02
As the U.S. population ages and dementia cases rise, many people are asking whether it is possible to prevent this devastating disease. According to a new study, the answer may be on your plate: People who followed a dietary pattern known as the MIND diet were significantly less likely to develop Alzheimer’s disease or related forms of dementia.
The MIND diet, which stands for Mediterranean-DASH Intervention for Neurodegenerative Delay, combines the Mediterranean diet with the blood pressure-lowering DASH (Dietary Approaches to Stop Hypertension) diet and also emphasizes proven brain-healthy ...
Study finds seniors are money savvy – until dementia sets in
2025-06-02
Older adults are quite aware of their financial abilities – and these abilities actually improve with age – that is, until dementia sets in, according to new research from Binghamton University, State University of New York.
From paying bills to making change, knowing how to handle money is necessary to live and thrive in society. But what happens as we get older? Do our financial abilities decline and if so, are we even aware of our own shortcomings?
To examine this, a team of researchers led by Binghamton University psychologist ...
Synthetic compound shows promise against multidrug resistance
2025-06-02
Highlights:
Infections by antimicrobial resistant (AMR) pathogens are a leading cause of death worldwide, with more than 1 million deaths annually, highlighting the need for new treatments.
Researchers have synthesized a new compound called infuzide that shows activity against resistant strains of pathogens.
Infuzide works against known, problematic gram-positive pathogens.
In lab and mouse tests, infuzide reduced bacterial populations, suggesting it might be useful as a new treatment for drug-resistant infections.
Washington, D.C.—Antimicrobial ...
Researchers recreate ancient Egyptian blues
2025-06-02
PULLMAN, Wash.--A team of Washington State University-led researchers has recreated the world's oldest synthetic pigment, called Egyptian blue, which was used in ancient Egypt about 5,000 years ago.
Reporting in the journal, NPJ Heritage Science, the researchers used a variety of raw materials and heating times to develop 12 recipes for the pigments, providing useful information for archaeologists and conservation scientists who study the ancient Egyptian materials. The work was done in collaboration with Carnegie Museum of ...
Immunotherapy before surgery improves lung cancer survival in global clinical trial led by Irish cancer specialist
2025-06-02
Results from a phase 3 clinical trial published in the New England Journal of Medicine, today (June 2nd) show that patients with lung cancer who received an immunotherapy drug, nivolumab, along with standard chemotherapy before surgery had improved long term survival compared to those who received chemotherapy alone, at 5 years after completing treatment. Prof. Patrick Forde of the Trinity St. James’s Cancer Institute (TSJCI), Trinity College Dublin School of Medicine presented the findings at the American ...
LAST 30 PRESS RELEASES:
Study reveals global inequalities in cancer research funding
England’s forgotten first king deserves to be famous, says Æthelstan biographer as anniversaries approach
Experts urge the medical profession to confront the global arms industry
Personalized risk messages fail to boost colorectal cancer screening participation
Something from nothing: Physicists model vacuum tunnelling in a 2D superfluid
CRISPR’s efficiency triples with DNA-wrapped nanoparticles
For the first time in 40 Years, Panama’s deep and cold ocean waters failed to emerge, possibly affecting fisheries and coral health
Depression may make learning to avoid unpleasant events harder
Study sheds light on how pediatric brain tumors grow
Rare seasonal brain shrinkage in shrews is driven by water loss, not cell death
AI co-pilot boosts noninvasive brain-computer interface by interpreting user intent
Black adults face heart failure nearly 14 years earlier than white patients
Study detects multidrug-resistant KPC-producing bacteria in Chilean wastewater for the first time
New artificial intelligence model accurately identifies which atrial fibrillation patients need blood thinners to prevent stroke
Safety of factor XI inhibition with abelacimab in atrial fibrillation by kidney function
Combination of mini-camera and AI predicts recurrent heart attack
Study Reveals Details of Overactive Immune System in Patients with Chronic Fatigue Syndrome (ME/CFS)
UTSA and UT Health San Antonio complete merger to become The University of Texas at San Antonio
Helicobacter pylori screening after acute myocardial infarction
Solar Orbiter traces superfast electrons back to Sun
GaN-based electron beam technology from Nagoya University startup poised to overcome critical semiconductor manufacturing challenges at KIOXIA
Circle versus rectangle: Finding ‘Earth 2.0’ may be easier using a new telescope shape
Metformin changes blood metal levels in humans
Long-term anticoagulation discontinuation after catheter ablation for atrial fibrillation
Fractional flow reserve–guided complete vs culprit-only revascularization in non–ST-elevation myocardial infarction and multivessel disease
Participation of women in cardiovascular trials from 2017 to 2023
Semaglutide and tirzepatide in patients with heart failure with preserved ejection fraction
Changes in biology of internal fat may be the leading cause of heart failure
Transcatheter or surgical treatment of patients with aortic stenosis at low to intermediate risk
Promising new drug for people with stubborn high blood pressure
[Press-News.org] Trends in past-month cannabis use among older adultsJAMA Internal Medicine